Ted Love, Global Blood Therapeutics CEO

Up­dat­ed: Pfiz­er scoops up Glob­al Blood Ther­a­peu­tics and its sick­le cell ther­a­pies for $5.4B

Pfiz­er is drop­ping $5.4 bil­lion to ac­quire Glob­al Blood Ther­a­peu­tics.

Just ahead of the week­end, word got out that Pfiz­er was close to clinch­ing a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.